HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
2.485
-0.095 (-3.68%)
Dec 3, 2024, 1:54 PM EST - Market open
HOOKIPA Pharma Revenue
HOOKIPA Pharma had revenue of $4.70M in the quarter ending September 30, 2024, a decrease of -31.51%. This brings the company's revenue in the last twelve months to $50.00M, up 143.30% year-over-year. In the year 2023, HOOKIPA Pharma had annual revenue of $20.13M with 41.27% growth.
Revenue (ttm)
$50.00M
Revenue Growth
+143.30%
P/S Ratio
0.63
Revenue / Employee
$279,324
Employees
179
Market Cap
29.96M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 72.71M |
IRIDEX | 48.43M |
Allurion Technologies | 34.75M |
Precision Optics Corporation | 18.98M |
Daré Bioscience | 1.88M |
Longeveron | 1.85M |
Pluri | 598.00K |
HOOK News
- 21 days ago - HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker - GlobeNewsWire
- 4 weeks ago - HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - GlobeNewsWire
- 4 weeks ago - HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer - GlobeNewsWire
- 2 months ago - HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - GlobeNewsWire
- 2 months ago - Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm - Business Wire
- 3 months ago - HOOKIPA Pharma Announces Board of Directors Changes - GlobeNewsWire
- 3 months ago - HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire